Epidemiology of lung cancer and lung cancer screening programs in China and the United States
- PMID: 31600530
- DOI: 10.1016/j.canlet.2019.10.009
Epidemiology of lung cancer and lung cancer screening programs in China and the United States
Abstract
Lung cancer is a heterogeneous disease that is impacted by environmental exposures and by constitutional genetic or epigenetic susceptibilities to disease development and progression. The United States and China have distinct and diverse populations and geographic environmental exposures that contribute to unique patterns of lung cancer incidence and mortality. In this paper, the authors compare trends of incidence and mortality of lung cancer in the US and China, and the impact on lung cancer screening programs in the two countries. It is worth noting that the mortality of lung cancer in the US has decreased gradually while in China it is still increasing over recent years. While decreasing smoking prevalence and the impact of clean air legislation have helped to mitigate the trend in the US relative to China, the increasingly widespread implementation of lung cancer chest CT screening is expected to impact lung cancer incidence and mortality in both countries. Currently there are few studies to compare the environmental and genetic risk factors for US and Chinese populations with regards to lung cancer incidence and mortality. The authors discuss the impact of gender and exposure risks, mainly smoking and environmental pollutants. Of high importance is the incidence of lung cancer in never smokers that is significantly higher in China than in the United States; this is particularly notable in women. These data suggest inclusion of ambient air pollution exposure and gender into lung cancer risk prognostic models to better capture high-risk individuals, especially for non-smoking women.
Keywords: ETS; Incidence; LDCT; Mortality; PM2.5.
Copyright © 2019 Elsevier B.V. All rights reserved.
Similar articles
-
A 16-year evaluation of opportunistic lung cancer screening with low-dose CT in China: comparative findings between non-smokers and smokers.BMC Cancer. 2024 Oct 28;24(1):1322. doi: 10.1186/s12885-024-13056-1. BMC Cancer. 2024. PMID: 39465408 Free PMC article.
-
Assessing Lung Cancer Absolute Risk Trajectory Based on a Polygenic Risk Model.Cancer Res. 2021 Mar 15;81(6):1607-1615. doi: 10.1158/0008-5472.CAN-20-1237. Epub 2021 Jan 20. Cancer Res. 2021. PMID: 33472890 Free PMC article.
-
Predicting Lung Cancer Occurrence in Never-Smoking Females in Asia: TNSF-SQ, a Prediction Model.Cancer Epidemiol Biomarkers Prev. 2020 Feb;29(2):452-459. doi: 10.1158/1055-9965.EPI-19-1221. Epub 2019 Dec 17. Cancer Epidemiol Biomarkers Prev. 2020. PMID: 31848206
-
Epidemiology of lung cancer in women: risk factors, survival, and screening.AJR Am J Roentgenol. 2011 Feb;196(2):287-95. doi: 10.2214/AJR.10.5412. AJR Am J Roentgenol. 2011. PMID: 21257878 Review.
-
Lung cancer screening.Am J Respir Crit Care Med. 2015 Jan 1;191(1):19-33. doi: 10.1164/rccm.201410-1777CI. Am J Respir Crit Care Med. 2015. PMID: 25369325 Review.
Cited by
-
KIFC3 promotes the proliferation, migration and invasion of non-small cell lung cancer through the PI3K/AKT signaling pathway.Sci Rep. 2024 Sep 3;14(1):20471. doi: 10.1038/s41598-024-71602-0. Sci Rep. 2024. PMID: 39227687 Free PMC article.
-
SH-1028, An Irreversible Third-Generation EGFR TKI, Overcomes T790M-Mediated Resistance in Non-Small Cell Lung Cancer.Front Pharmacol. 2021 Apr 27;12:665253. doi: 10.3389/fphar.2021.665253. eCollection 2021. Front Pharmacol. 2021. PMID: 33986687 Free PMC article.
-
Lung Cancer Occurrence-Correlation with Serum Chromium Levels and Genotypes.Biol Trace Elem Res. 2021 Apr;199(4):1228-1236. doi: 10.1007/s12011-020-02240-6. Epub 2020 Jul 9. Biol Trace Elem Res. 2021. PMID: 32648197 Free PMC article.
-
Patient's experiences of coughing after lung cancer surgery: A multicenter qualitative study.Cancer Med. 2024 Jan;13(2):e6993. doi: 10.1002/cam4.6993. Cancer Med. 2024. PMID: 38348918 Free PMC article.
-
The value of net influx constant based on FDG PET/CT dynamic imaging in the differential diagnosis of metastatic from non-metastatic lymph nodes in lung cancer.Ann Nucl Med. 2024 Nov;38(11):904-912. doi: 10.1007/s12149-024-01964-y. Epub 2024 Jul 29. Ann Nucl Med. 2024. PMID: 39078558 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical